Shanghai Junshi Biosciences to Acquire Stake in Anlingke Biopharmaceutical for Cancer Therapy Programs
China-based Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has announced its intention to...
Broncus Medical Inc. to Acquire Fibernova Holding Corporation for USD 2.7 Million
Broncus Medical Inc., (HKG: 2216) a provider of lung disease precision intervention solutions with operations...
Lepu Medical Technology Receives NMPA Approval for MemoSorb Biodegradable PFO Occluder
China-based cardiovascular disease solutions provider Lepu Medical Technology (Beijing) Co., Ltd (SHE: 300003) has announced...
EA Pharma and TransThera Sciences Collaborate on GI and Liver Disease Therapies
Japan-based EA Pharma Co., Ltd and China-headquartered TransThera Sciences (Nanjing) Inc. have jointly announced the...
GRIT Biotechnology Secures RMB 400 Million in Series B Financing to Advance TIL Pipeline
China-based GRIT Biotechnology has announced the completion of a Series B financing round, raising RMB...
Oriomics Secures Series B+ Funding to Advance Liver and Digestive Cancer Screening
Hangzhou-based Oriomics, a specialist in cancer screening based on circulating tumor DNA (ctDNA) methylation detection,...
Sichuan Kelun Pharmaceutical Submits Biosimilar Cetuximab for NMPA Approval
Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422), through its innovative drug development subsidiary Sichuan Kelun-Biotech...
Biotyx Medical Secures Over RMB 200 Million in Series B Financing for Iron-Based Stents
China-based Biotyx Medical (Shenzhen) Co.,Ltd, known as the world’s only developer of iron-based absorbable stents,...
United Laboratories’ UBT251 Receives Tacit Approval for NAFLD Clinical Study in China
Hong Kong firm United Laboratories International Holdings Ltd (HKG: 3933) has announced that its Category...
Abbisko Therapeutics Receives EMA Approval for Phase III Study of Pimicotinib for TGCT
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced that it has received approval...
AriBio Files for Phase III Clinical Trial Approval in China for Alzheimer’s Drug AR1001
South Korean clinical-stage biotech AriBio Co. has announced the filing for Phase III clinical trial...
Allist Pharmaceuticals and ArriVent Biopharma Release Promising Interim Data on Furmonertinib for NSCLC
Shanghai-based biotech Allist Pharmaceuticals Co., Ltd and its US partner ArriVent Biopharma Inc. have jointly...
iotaSciences Partners with Quantum Design China for Single-Cell Handling Platform Distribution
UK-based cell-line engineering firm iotaSciences has announced an exclusive partnership with Quantum Design China, a...
BMS Announces Positive Outcomes for BMS-986278 in Progressive Pulmonary Fibrosis Study
Bristol-Myers Squibb (BMS; NYSE: BMY) has released the final results from a Phase II trial...
Eurofarma Invests in Abcuro as Part of $100 Million Disruptive Startups and Biotech Initiative
Brazil-based multinational company (MNC) Eurofarma has announced an investment in US immunotherapy developer Abcuro as...
EMA Reviews Janssen’s Balversa for Advanced Urothelial Carcinoma with FGFR3 Alterations
The European Medicines Agency (EMA) has accepted for review a filing made by the Janssen...
United Laboratories Receives Tacit Approval for JAK1 Inhibitor TUL01101 Clinical Trial
Hong Kong-listed United Laboratories International Holdings Ltd (HKG: 3933) has announced tacit clinical trial approval...
Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for Phase Ib/III Study of Dalpiciclib in mHSPC
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has announced that it has received approval...
Otsuka and Shape Therapeutics Partner on Ophthalmology Gene Therapies Development
Japan drug maker Otsuka (OTCMKTS: OTSKY) and US firm Shape Therapeutics have announced a strategic...
Roche and Alnylam’s Zilebesiran Achieves Primary Endpoint in Hypertension Phase II Trial
Roche (SWX: ROG) and Alnylam (NASDAQ: ALNY) have announced that a Phase II trial for...